Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transdermal therapy for overactive bladder: present and future.

Victor W Nitti

    Reviews in Urology
    |September 21, 2006
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Trends in the Treatment of Stress Urinary Incontinence in a Tertiary Care Center After the Introduction of Polyacrylamide Hydrogel.

    Neurourology and urodynamics·2025
    Same author

    Concomitant anti-incontinence procedure at the time of prolapse repair: Sometimes.

    The French journal of urology·2025
    Same author

    A Randomized Non-Inferiority Trial for Telemedicine in the Follow-Up of Overactive Bladder Patients.

    Neurourology and urodynamics·2025
    Same author

    Efficacy and safety of onabotulinumtoxinA for the treatment of overactive bladder in men and women: A pooled analysis.

    Neurourology and urodynamics·2024
    Same author

    Melatonin and melatonin receptor agonists in the treatment of nocturia: A systematic review.

    Neurourology and urodynamics·2024
    Same author

    Bladder outlet obstruction in women: Advanced evaluation.

    Neurourology and urodynamics·2024
    Same journal

    Erratum: Author's Name Correction for "From Radical to Partial Nephrectomy in the Setting of Solitary Functioning Kidney: Neoadjuvant Treatment of Renal Cell Carcinoma".

    Reviews in urology·2021
    Same journal

    Update in Female Hormonal Therapy: What the Urologist Should Know: NYU Case of the Month, December 2020.

    Reviews in urology·2021
    Same journal

    Genetic Mutations Associated With Prostate Cancer and Normal Serum PSA and DRE-Implications for Prostate Cancer Screening and Management: NYU Case of the Month, November 2020.

    Reviews in urology·2021
    Same journal

    Surgical Management of the "Large" Prostate: The Robotic Simple Prostatectomy: NYU Case of the Month, October 2020.

    Reviews in urology·2021
    Same journal

    Cryptozoospermia Associated With Genital Tucking Behavior in a Transwoman.

    Reviews in urology·2021
    Same journal

    Washington Roundup.

    Reviews in urology·2021
    See all related articles

    Transdermal oxybutynin offers a convenient overactive bladder (OAB) treatment with fewer side effects. While effective, further improvements in efficacy and skin irritation are needed for this OAB therapy.

    Area of Science:

    • Pharmacology
    • Urology
    • Drug Delivery Systems

    Background:

    • Transdermal drug delivery bypasses the gastrointestinal tract, offering advantages like improved bioavailability and reduced side effects.
    • For overactive bladder (OAB), transdermal therapy presents a convenient alternative to oral medications, potentially improving the side-effect profile and plasma concentrations.
    • Physicians' unfamiliarity with transdermal OAB treatments is a barrier, though successful applications in pain management, hormone replacement, and contraception offer valuable insights.

    Purpose of the Study:

    • To evaluate the efficacy and tolerability of the transdermal oxybutynin system for overactive bladder (OAB) treatment.
    • To compare the benefits of transdermal oxybutynin delivery against oral preparations for OAB management.
    • To identify areas for improvement in transdermal systems for OAB, focusing on enhanced efficacy and management of local skin reactions.

    Related Experiment Videos

    Main Methods:

    • Review of existing literature on transdermal drug delivery systems.
    • Analysis of clinical data regarding the transdermal oxybutynin system for OAB.
    • Comparison of transdermal oxybutynin's efficacy and side-effect profile with oral OAB medications.

    Main Results:

    • The transdermal oxybutynin system for OAB demonstrates efficacy comparable to standard oral doses.
    • This delivery method significantly reduces oxybutynin metabolites, leading to a low incidence of anticholinergic side effects.
    • The treatment offers convenience and an improved side-effect profile for OAB patients.

    Conclusions:

    • Transdermal oxybutynin is an effective treatment option for overactive bladder (OAB), providing comparable efficacy to oral agents with a favorable side-effect profile.
    • Further research and development are warranted to enhance the efficacy of transdermal systems beyond current oral medications.
    • Addressing and mitigating local skin reactions at the application site is crucial for optimizing transdermal OAB therapy.